{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:20:02Z","timestamp":1793053202263,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ejogrb.2010.02.029","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T07:52:47Z","timestamp":1268380367000},"page":"166-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos"],"prefix":"10.1016","volume":"150","author":[{"given":"Kingshuk","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek A.","family":"Gelbaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano G.","family":"Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2010.02.029_bib1","series-title":"Preservation of fertility","article-title":"Female reproductive aging: concepts and consequences","author":"De Bruin","year":"2004"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib3","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-mullerian hormone attenuates the effect of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib5","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1210\/endo.136.11.7588229","article-title":"Anti-mullerian hormone and anti-mullerian hormone type 2 receptor messenger ribonucleic acid expressions in rat ovaries during postnatal development, the estrous cycle and gonadotrophin-induced follicle growth","volume":"136","author":"Baarends","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Anti-mullerian hormone serum levels: a putative marker of ovarian aging","volume":"77","author":"De Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib8","first-page":"1","article-title":"Anti-M\u00fcllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history","volume":"24","author":"Nardo","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","article-title":"High reproducibility of serum anti-mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status","volume":"20","author":"Fanchin","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib10","article-title":"Circulating basal anti-mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization","author":"Nardo","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive aging","volume":"8","author":"te Velde","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib12","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","article-title":"Basal level of anti-mullerian hormone is associated with oocyte quality in stimulated cycles","volume":"21","author":"Ebner","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.fertnstert.2005.01.115","article-title":"Per-follicle measurements indicate that anti-m\u00fcllerian hormone secretion is modulated by the extent of follicular development and luteinisation and may reflect qualitatively the ovarian follicular status","volume":"84","author":"Fanchin","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","article-title":"Anti-mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality","volume":"16","author":"Fong","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","article-title":"Anti-mullerian hormone as a predictor of IVF outcome","volume":"14","author":"Lekamge","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","article-title":"Anti-mullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection","volume":"1","author":"Smeenk","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib18","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"Van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment","volume":"20","author":"Pe\u00f1arrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","article-title":"Serum anti-mullerian hormone\/mullerian inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle stimulating hormone, inhibin B or estradiol","volume":"82","author":"Hazout","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib21","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1472-6483(10)60859-0","article-title":"Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility","volume":"12","author":"Van Rooij","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib23","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib24","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/den108","article-title":"Relevance of anti-mullerian hormone measurement in a routine IVF program","volume":"23","author":"Gnoth","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humrep\/dei270","article-title":"M\u00fcllerian inhibitory substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology","volume":"21","author":"Silberstein","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2010.02.029_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/humrep\/del403","article-title":"Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval","volume":"22","author":"Holte","year":"2007","journal-title":"Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211510000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211510000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:23:12Z","timestamp":1759555392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211510000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0301211510000953"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2010.02.029","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2010.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}